Adiposity and cancer: a Mendelian randomization analysis in the UK biobank
Background Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities. Methods We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We c...
Saved in:
| Published in | International Journal of Obesity Vol. 45; no. 12; pp. 2657 - 2665 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.12.2021
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0307-0565 1476-5497 1476-5497 |
| DOI | 10.1038/s41366-021-00942-y |
Cover
| Abstract | Background
Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities.
Methods
We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either “unfavourable” (82 SNPs), “favourable” (24 SNPs) or “neutral” metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity.
Results
All genetic instruments had a strong association with BMI (
p
< 1 × 10
−300
for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer.
Conclusions
Higher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk. |
|---|---|
| AbstractList | Background Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities. Methods We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either "unfavourable" (82 SNPs), "favourable" (24 SNPs) or "neutral" metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity. Results All genetic instruments had a strong association with BMI (p < 1 × 10.sup.-300 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer. Conclusions Higher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk. Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities. We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either "unfavourable" (82 SNPs), "favourable" (24 SNPs) or "neutral" metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity. All genetic instruments had a strong association with BMI (p < 1 × 10.sup.-300 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer. Higher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk. Background Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities. Methods We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either “unfavourable” (82 SNPs), “favourable” (24 SNPs) or “neutral” metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity. Results All genetic instruments had a strong association with BMI ( p < 1 × 10 −300 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer. Conclusions Higher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk. BackgroundObservational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities.MethodsWe used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either “unfavourable” (82 SNPs), “favourable” (24 SNPs) or “neutral” metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity.ResultsAll genetic instruments had a strong association with BMI (p < 1 × 10−300 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer.ConclusionsHigher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk. Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities. We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either "unfavourable" (82 SNPs), "favourable" (24 SNPs) or "neutral" metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity. All genetic instruments had a strong association with BMI (p < 1 × 10 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer. Higher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk. Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities.BACKGROUNDObservational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic abnormalities.We used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either "unfavourable" (82 SNPs), "favourable" (24 SNPs) or "neutral" metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity.METHODSWe used information from 321,472 participants in the UK biobank, including 30,561 cases of obesity-related cancer. We constructed three genetic instruments reflecting higher adiposity together with either "unfavourable" (82 SNPs), "favourable" (24 SNPs) or "neutral" metabolic profile (25 SNPs). We looked at associations with 14 types of cancer, previously suggested to be associated with obesity.All genetic instruments had a strong association with BMI (p < 1 × 10-300 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer.RESULTSAll genetic instruments had a strong association with BMI (p < 1 × 10-300 for all). The instrument reflecting unfavourable adiposity was also associated with higher CRP, HbA1c and adverse lipid profile, while instrument reflecting metabolically favourable adiposity was associated with lower HbA1c and a favourable lipid profile. In MR-inverse-variance weighted analysis unfavourable adiposity was associated with an increased risk of non-hormonal cancers (OR = 1.22, 95% confidence interval [CI]:1.08, 1.38), but a lower risk of hormonal cancers (OR = 0.80, 95%CI: 0.72, 0.89). From individual cancers, MR analyses suggested causal increases in the risk of multiple myeloma (OR = 1.36, 95%CI: 1.09, 1.70) and endometrial cancer (OR = 1.77, 95%CI: 1.16, 2.68) by greater genetically instrumented unfavourable adiposity but lower risks of breast and prostate cancer (OR = 0.72, 95%CI: 0.61, 0.83 and OR = 0.81, 95%CI: 0.68, 0.97, respectively). Favourable or neutral adiposity were not associated with the odds of any individual cancer.Higher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk.CONCLUSIONSHigher adiposity associated with a higher risk of non-hormonal cancer but a lower risk of some hormone related cancers. Presence of metabolic abnormalities might aggravate the adverse effects of higher adiposity on cancer. Further studies are warranted to investigate whether interventions on adverse metabolic health may help to alleviate obesity-related cancer risk. |
| Audience | Academic |
| Author | Mulugeta, Anwar Boyle, Terry Mäkinen, Ville-Petteri Hyppönen, Elina Ahmed, Muktar Lee, S. Hong |
| Author_xml | – sequence: 1 givenname: Muktar orcidid: 0000-0002-9524-7027 surname: Ahmed fullname: Ahmed, Muktar organization: Australian Centre for Precision Health, Unit of Clinical and Health Sciences and Unit of Allied Health and Human Performance, University of South Australia, Department of Epidemiology, Faculty of Public Health, Jimma University Institute of Health, South Australian Health and Medical Research Institute – sequence: 2 givenname: Anwar orcidid: 0000-0002-8018-3454 surname: Mulugeta fullname: Mulugeta, Anwar organization: Australian Centre for Precision Health, Unit of Clinical and Health Sciences and Unit of Allied Health and Human Performance, University of South Australia, South Australian Health and Medical Research Institute, Department of Pharmacology and Clinical Pharmacy, College of Health Sciences – sequence: 3 givenname: S. Hong surname: Lee fullname: Lee, S. Hong organization: Australian Centre for Precision Health, Unit of Clinical and Health Sciences and Unit of Allied Health and Human Performance, University of South Australia, South Australian Health and Medical Research Institute – sequence: 4 givenname: Ville-Petteri orcidid: 0000-0002-7262-2656 surname: Mäkinen fullname: Mäkinen, Ville-Petteri organization: Australian Centre for Precision Health, Unit of Clinical and Health Sciences and Unit of Allied Health and Human Performance, University of South Australia, Computational Systems Biology Program, Precision Medicine Theme, South Australian Health and Medical Research Institute – sequence: 5 givenname: Terry orcidid: 0000-0001-6741-330X surname: Boyle fullname: Boyle, Terry organization: Australian Centre for Precision Health, Unit of Clinical and Health Sciences and Unit of Allied Health and Human Performance, University of South Australia, South Australian Health and Medical Research Institute – sequence: 6 givenname: Elina orcidid: 0000-0003-3670-9399 surname: Hyppönen fullname: Hyppönen, Elina email: Elina.Hypponen@unisa.edu.au organization: Australian Centre for Precision Health, Unit of Clinical and Health Sciences and Unit of Allied Health and Human Performance, University of South Australia, South Australian Health and Medical Research Institute |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34453097$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1vFCEYgImpsdvqH_BgJjExvUx9-QZvm8b6VePFngnLsF3qDKwwcxh_vWy3WtuYhgMJPA-8X0foIKboEXqJ4RQDVW8Lw1SIFghuATQj7fwELTCTouVMywO0AAqyBS74IToq5RoAOAfyDB1SxjgFLRfo87IL21TCODc2do2z0fn8rrHNVx873wcbm1wv0hB-2TGkWCnbzyWUJsRm3Pjm8kuzCmll44_n6Ona9sW_uN2P0eX5--9nH9uLbx8-nS0vWsckHVtPneu6TnnBCXWgibJCE6eYsk5asiLQccq55xi0rblZJrEkjFdZe8cYPUYn-3e3Of2cfBnNEIrzfW-jT1MxhAsBDKTCFX39AL1OU64ZVEoAYAxEyDvqyvbehLhOY7Zu96hZCkWpFlqrSp3-h6qr80NwtTPrUM_vCW_-ETbe9uOmpH7albHcB1_dRjmtBt-ZbQ6DzbP506UKkD3gciol-_VfBIPZjYLZj4Kp5TI3o2DmKqkHkgvjTQ9r3KF_XKV7tdR_4pXPd2V7xPoNhKXDjA |
| CitedBy_id | crossref_primary_10_1002_acr_24884 crossref_primary_10_3390_cancers16244205 crossref_primary_10_1186_s12885_022_10170_w crossref_primary_10_1007_s10555_022_10054_2 crossref_primary_10_1016_j_metabol_2022_155342 crossref_primary_10_3390_ijms222111430 crossref_primary_10_1038_s41598_024_53926_z crossref_primary_10_3389_fendo_2022_783150 crossref_primary_10_1186_s13075_023_03157_w crossref_primary_10_1038_s41416_022_02053_5 crossref_primary_10_1007_s10552_025_01980_x crossref_primary_10_1038_s41598_023_46797_3 crossref_primary_10_1093_postmj_qgad009 crossref_primary_10_1111_acps_13614 crossref_primary_10_2147_COPD_S495073 crossref_primary_10_1016_j_schres_2023_09_030 crossref_primary_10_3233_ADR_230126 crossref_primary_10_3390_cancers15194884 crossref_primary_10_3389_fmicb_2024_1325466 crossref_primary_10_3389_fmicb_2024_1363776 crossref_primary_10_1016_j_jad_2024_07_100 |
| Cites_doi | 10.1038/s41588-019-0379-x 10.1038/oby.2009.399 10.1111/cas.14667 10.1111/nyas.13230 10.1158/1055-9965.EPI-17-0495 10.2196/14325 10.5324/nje.v20i2.1334 10.1038/s41574-018-0126-x 10.1038/bcj.2017.48 10.1186/s12967-016-0772-5 10.1016/S2468-1253(19)30294-8 10.1002/ijc.28872 10.1136/bmj.k601 10.1002/gepi.21965 10.1038/s41467-019-14156-4 10.1056/NEJMsr1606602 10.1158/1055-9965.EPI-14-1309 10.1002/cphy.c170008 10.1093/ije/dyw158 10.1016/j.endoen.2011.05.008 10.1093/carcin/21.3.427 10.1093/jnci/dju252 10.1007/s10552-015-0654-9 10.1158/1055-9965.EPI-16-0147 10.1093/jnci/92.14.1151 10.5114/aoms.2013.33181 10.1146/annurev-pathol-012615-044359 10.1016/S0140-6736(08)60269-X 10.1101/2020.04.02.20049031 10.1182/bloodadvances.2020001502 10.1158/0008-5472.CAN-12-4213 10.1093/ije/dyv080 10.1371/journal.pmed.1002105 10.1016/j.ejca.2013.03.015 10.1007/s10519-013-9607-9 10.1093/ije/dyx102 10.1161/01.CIR.0000111245.75752.C6 10.1093/annonc/mdq464 10.1038/s41467-019-10128-w 10.1093/aje/kwx246 10.1038/nrendo.2014.94 10.1093/ije/dyu005 10.1038/s41598-018-36186-6 10.1038/nature14177 10.1016/S2589-7500(19)30028-7 10.7554/eLife.34408 10.1111/opo.12596 10.1093/ije/dyy202 10.1038/s41467-018-04124-9 10.1016/S1470-2045(09)70170-6 10.1186/s12916-017-0876-7 10.1371/journal.pmed.1001779 10.1158/1078-0432.CCR-15-2239 10.1530/ERC-12-0229 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Nature Limited 2021 2021. The Author(s), under exclusive licence to Springer Nature Limited. COPYRIGHT 2021 Nature Publishing Group The Author(s), under exclusive licence to Springer Nature Limited 2021. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Limited 2021 – notice: 2021. The Author(s), under exclusive licence to Springer Nature Limited. – notice: COPYRIGHT 2021 Nature Publishing Group – notice: The Author(s), under exclusive licence to Springer Nature Limited 2021. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7TS 7X2 7X7 7XB 88E 88G 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0K M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
| DOI | 10.1038/s41366-021-00942-y |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Agricultural Science Collection ProQuest Health & Medical Complete ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Psychology Database Biological science database Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health Diet & Clinical Nutrition Recreation & Sports |
| EISSN | 1476-5497 |
| EndPage | 2665 |
| ExternalDocumentID | A683396998 34453097 10_1038_s41366_021_00942_y |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom United Kingdom--UK |
| GeographicLocations_xml | – name: United Kingdom – name: United Kingdom--UK |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MC_PC_17228 – fundername: Medical Research Council grantid: MC_QA137853 |
| GroupedDBID | .55 .GJ 29J 36B 39C 5RE 7X2 7X7 8R4 8R5 A8Z ABDBF ABOCM ABUWG ACUHS ADBBV AFFNX AI. ALMA_UNASSIGNED_HOLDINGS ATCPS AZQEC B0M BAWUL BENPR BHPHI BPHCQ DIK DWQXO EAD EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ HCIFZ IAO IHR ITC J5H M0K M1P M2M MVM NAO OK1 Q2X RNT RNTTT SV3 TUS VH1 WH7 X7M ZGI ZXP ~8M AAYXX CITATION --- -Q- ..I .L3 .XZ 0R~ 1CY 2FS 2WC 4.4 406 53G 5GY 70F 88E 8AO 8C1 8FE 8FH 8FI 8FJ AACDK AAHBH AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABFSG ABIVO ABJNI ABLJU ABRTQ ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACZOJ ADHUB ADXHL AEFQL AEJRE AEMSY AENEX AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV AMYLF APEBS ATHPR AXYYD AYFIA BBNVY BKKNO BVXVI CCPQU CGR CS3 CUY CVF DNIVK DPUIP DU5 E3Z EBLON ECM EE. EIF EIOEI EJD FDQFY FERAY FIGPU FIZPM FSGXE HMCUK HZ~ IHW INH INR IPY IWAJR JSO JZLTJ KQ8 L7B M7P NPM NQJWS O9- OVD P2P P6G PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PSYQQ RNS ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG UKHRP ~KM 3V. 7T2 7TK 7TS 7XB 8FK C1K K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO |
| ID | FETCH-LOGICAL-c473t-e3ccddd8e6523c0928a692c848ac7a2b20d5355e5109a021a47172454739ec443 |
| IEDL.DBID | BENPR |
| ISSN | 0307-0565 1476-5497 |
| IngestDate | Thu Sep 04 20:24:47 EDT 2025 Mon Oct 06 18:26:21 EDT 2025 Mon Oct 20 22:17:58 EDT 2025 Mon Oct 20 16:44:53 EDT 2025 Thu May 22 21:21:19 EDT 2025 Mon Jul 21 06:03:08 EDT 2025 Wed Oct 01 03:43:18 EDT 2025 Thu Apr 24 22:57:27 EDT 2025 Fri Feb 21 02:39:08 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | 2021. The Author(s), under exclusive licence to Springer Nature Limited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c473t-e3ccddd8e6523c0928a692c848ac7a2b20d5355e5109a021a47172454739ec443 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-3670-9399 0000-0002-8018-3454 0000-0002-7262-2656 0000-0001-6741-330X 0000-0002-9524-7027 |
| PMID | 34453097 |
| PQID | 2600110267 |
| PQPubID | 38864 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2566040781 proquest_journals_2600110267 gale_infotracmisc_A683396998 gale_infotracacademiconefile_A683396998 gale_healthsolutions_A683396998 pubmed_primary_34453097 crossref_primary_10_1038_s41366_021_00942_y crossref_citationtrail_10_1038_s41366_021_00942_y springer_journals_10_1038_s41366_021_00942_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-01 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | International Journal of Obesity |
| PublicationTitleAbbrev | Int J Obes |
| PublicationTitleAlternate | Int J Obes (Lond) |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | MasudaTOgawaKKamataniYMurakamiYKimuraTOkadaYA Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in JapaneseCancer Sci20201114646511:CAS:528:DC%2BB3cXitFGlsLbO32981178773416210.1111/cas.14667 SudlowCGallacherJAllenNBeralVBurtonPDaneshJUK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old agePLoS Med201512e100177925826379438046510.1371/journal.pmed.1001779 GkatzionisABurgessSContextualizing selection bias in Mendelian randomization: how bad is it likely to be?Int J Epidemiol2019486917013032542210.1093/ije/dyy202 DallalCMBrintonLABauerDCBuistDSCauleyJAHueTFObesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohortEndocr Relat Cancer201320151601:CAS:528:DC%2BC3sXlt1WnsL4%3D23222000403832610.1530/ERC-12-0229 KabatGCKimMYLeeJSHoGYGoingSBBeebe-DimmerJMetabolic obesity phenotypes and risk of breast cancer in postmenopausal womenCancer Epidemiol Biomarkers Prev2017261730528939589698633410.1158/1055-9965.EPI-17-0495 Flanders WD, Augestad LB Methodological issues in observational studies of obesity and mortality. Norsk Epidemiologi. 2011;20(2):143–148. HartwigFPDavey SmithGBowdenJRobust inference in summary data Mendelian randomization via the zero modal pleiotropy assumptionInt J Epidemiol20174619859829040600583771510.1093/ije/dyx102 PerryBLPescosolidoBABucholzKEdenbergHKramerJKupermanSGender-specific gene-environment interaction in alcohol dependence: the impact of daily life events and GABRA2Behav Genet2013434021423974430444104410.1007/s10519-013-9607-9 GrundySMBrewerHBJr.CleemanJISmithSCJr.LenfantCAmerican HeartADefinition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionCirculation200410943381474495810.1161/01.CIR.0000111245.75752.C6 GIANT. GIANT consortium data files. In. March 2019 ed, 2019. ParkJMorleyTSKimMCleggDJSchererPEObesity and cancer-mechanisms underlying tumour progression and recurrenceNat Rev Endocrinol201410455651:CAS:528:DC%2BC2cXpvFWgsb8%3D24935119437443110.1038/nrendo.2014.94 NMISystemic correlates of white adipose tissue inflammation in early-stage breast cancerClin. Cancer Res2016222283910.1158/1078-0432.CCR-15-2239 BowdenJDavey SmithGHaycockPCBurgessSConsistent estimation in mendelian randomization with some invalid instruments using a weighted median estimatorGenet Epidemiol2016403041427061298484973310.1002/gepi.21965 CoelhoMOliveiraTFernandesRBiochemistry of adipose tissue: an endocrine organArch Med Sci201391912001:CAS:528:DC%2BC3sXht1Kgsr3P23671428364882210.5114/aoms.2013.33181 CozzoAJFullerAMMakowskiLContribution of adipose tissue to development of cancerCompr Physiol201782378229357128580662710.1002/cphy.c170008 Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014;106(11):1–8. PainterJNO’MaraTAMarquartLWebbPMAttiaJMedlandSEGenetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancerCancer Epidemiol Biomarkers Prev20162515031027550749509308210.1158/1055-9965.EPI-16-0147 Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D et al. The MR-base platform supports systematic causal inference across the human phenome. Elife 2018;7:e34408. DixonSCNagleCMThriftAPPharoahPDPearceCLZhengWAdult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization studyInt J Epidemiol2016458849527401727564457310.1093/ije/dyw158 BowdenJDavey SmithGBurgessSMendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionInt J Epidemiol2015445122526050253446979910.1093/ije/dyv080 Álvarez-CastroPSangiao-AlvarellosSBrandón-SandáICordidoFEndocrine function in obesityEndocrinología y Nutrición (English Edition)2011584223210.1016/j.endoen.2011.05.008 WuPGiffordAMengXLiXCampbellHVarleyTMapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial EvaluationJMIR Med Inform20197e1432531553307691122710.2196/14325 WacholderSRothmanNCaporasoNPopulation stratification in epidemiologic studies of common genetic variants and cancer: quantification of biasJ Natl Cancer Inst200092115181:STN:280:DC%2BD3cvlvFeguw%3D%3D1090408810.1093/jnci/92.14.1151 Alicia RMartinMKYoichiroKamataniYukinoriOkadaBenjamin M.NealeMark JDalyClinical use of current polygenic risk scores may exacerbate health disparitiesNature Genetics2019515849110.1038/s41588-019-0379-x HyppönenEMulugetaAZhouASanthanakrishnanVKA data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK BiobankThe Lancet Digital Health20191e116e1263332326210.1016/S2589-7500(19)30028-7 Martinez-UserosJGarcia-FoncillasJObesity and colorectal cancer: molecular features of adipose tissueJ Transl Med20161426801617472267410.1186/s12967-016-0772-5 Biobank TU Genotyping and quality control of UK Biobank, a large-scale, extensively phenotyped prospective resource. 2015. WentMCornishAJLawPJKinnersleyBvan DuinMWeinholdNSearch for multiple myeloma risk factors using Mendelian randomizationBlood Adv20204217291:CAS:528:DC%2BB3cXis12ks7vP32433745725254110.1182/bloodadvances.2020001502 WentMSudALawPJJohnsonDCWeinholdNForstiAAssessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approachBlood Cancer J201771:STN:280:DC%2BC1cnptVCmuw%3D%3D28622301552039510.1038/bcj.2017.48 RenehanAGBariatric surgery, weight reduction, and cancer preventionThe Lancet Oncology20091064011955616410.1016/S1470-2045(09)70170-6 RenehanAGTysonMEggerMHellerRFZwahlenMBody-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet20083715697810.1016/S0140-6736(08)60269-X DengTLyonCJBerginSCaligiuriMAHsuehWAObesity, inflammation, and cancerAnnu Rev Pathol201611421491:CAS:528:DC%2BC28XotF2qtLk%3D2719345410.1146/annurev-pathol-012615-044359 QuailDFDannenbergAJThe obese adipose tissue microenvironment in cancer development and progressionNat Rev Endocrinol2019151395430459447637417610.1038/s41574-018-0126-x Perez-CornagoAApplebyPNPischonTTsilidisKKTjonnelandAOlsenATall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort studyBMC Med20171528701188550868710.1186/s12916-017-0876-7 TaylorRWGrantAMWilliamsSMGouldingASex differences in regional body fat distribution from pre- to postpubertyObesity (Silver Spring)2010181410610.1038/oby.2009.399 NagataNSakamotoKAraiTNiikuraRShimboTShinozakiMVisceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenomaInt J Cancer20141352273811:CAS:528:DC%2BC2cXlvFWntLs%3D2469206410.1002/ijc.28872 BurgessSFoleyCNAllaraEStaleyJRHowsonJMMA robust and efficient method for Mendelian randomization with hundreds of genetic variantsNat Commun2020111:CAS:528:DC%2BB3cXivFOgsbc%3D31953392696905510.1038/s41467-019-14156-4 FryALittlejohnsTJSudlowCDohertyNAdamskaLSprosenTComparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general populationAm J Epidemiol201718610263428641372586037110.1093/aje/kwx246 GuoYWarren AndersenSShuXOMichailidouKBollaMKWangQGenetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of european descentPLoS Med201613e100210527551723499502510.1371/journal.pmed.1002105 NiGvan der WerfJZhouXHypponenEWrayNRLeeSHGenotype-covariate correlation and interaction disentangled by a whole-genome multivariate reaction norm modelNat Commun20191031110177652761210.1038/s41467-019-10128-w DaviesNMeaThe effects of height and BMI on prostate cancer inidence and mortality: a mendelain randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortiumCancer Causes Control20152616031626387087459689910.1007/s10552-015-0654-9 WinklerTWGuntherFHollererSZimmermannMLoosRJKutalikZA joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implicationsNat Commun2018929769528595607910.1038/s41467-018-04124-9 CornishAJLawPJTimofeevaMPalinKFarringtonSMPallesCModifiable pathways for colorectal cancer: a mendelian randomisation analysisThe Lancet Gastroenterol Hepatol2020555623166858410.1016/S2468-1253(19)30294-8 ThriftAPGongJPetersUChang-ClaudeJRudolphASlatteryMLMendelian randomization study of body mass index and colorectal cancer riskCancer Epidemiol Biomarkers Prev20152410243125976416449096010.1158/1055-9965.EPI-14-1309 Biobank U UK Biobank Cancer Numbers Summary Report. In. UK: UK Biobank, 2020. Lauby-SecretanBScocciantiCLoomisDGrosseYBianchiniFStraifKBody fatness and cancer-viewpoint of the IARC Working GroupN Engl J Med2016375794827557308675486110.1056/NEJMsr1606602 PlotnikovDGuggenheimJAMendelian randomisation and the goal of inferring causation from observational studies in the vision sciencesOphthalmic Physiol Opt20193911253062874310.1111/opo.12596 NagleCMMarquartLBainCJO’BrienSLahmannPHQuinnMImpact of weight change and weight cycling on risk of different subtypes of endometrial cancerEur J Cancer2013492717261:STN:280:DC%2BC3srkvFWiuw%3D%3D2358343810.1016/j.ejca.2013.03.015 WCRF/AICR. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective A summary of the third Expert Report World Cancer Research Fund/American Institute for Cancer Research 2018. Report no.: Expert Report 2018. IttmannMHuangJRadaelliEMartinPSignorettiSSullivanRAnimal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeCancer Res2013732718361:CAS:528:DC%2BC3sXmvVShtLs%3D23610450364402110.1158/0008-5472.CAN-12-4213 LockeAEK Y Guo (942_CR9) 2016; 13 S Wacholder (942_CR55) 2000; 92 942_CR11 942_CR54 TW Winkler (942_CR20) 2018; 9 CM Dallal (942_CR42) 2013; 20 NM Davies (942_CR36) 2015; 26 942_CR7 G Ni (942_CR51) 2019; 10 SC Dixon (942_CR14) 2016; 45 A Perez-Cornago (942_CR37) 2017; 15 J Martinez-Useros (942_CR52) 2016; 14 D Plotnikov (942_CR8) 2019; 39 AJ Cornish (942_CR15) 2020; 5 CM Nagle (942_CR43) 2013; 49 RW Taylor (942_CR49) 2010; 18 CM Phillips (942_CR39) 2017; 1391 I NM (942_CR19) 2016; 22 T Deng (942_CR3) 2016; 11 H Takahashi (942_CR16) 2019; 9 942_CR24 AE Locke (942_CR26) 2015; 518 942_CR28 942_CR27 NMea Davies (942_CR13) 2015; 26 942_CR1 GC Kabat (942_CR38) 2017; 26 V Rosato (942_CR41) 2011; 22 B Lauby-Secretan (942_CR48) 2016; 375 M Ittmann (942_CR5) 2013; 73 P Álvarez-Castro (942_CR21) 2011; 58 JN Painter (942_CR40) 2016; 25 AP Thrift (942_CR10) 2015; 24 E Hyppönen (942_CR29) 2019; 1 942_CR35 942_CR34 M Went (942_CR46) 2017; 7 AG Renehan (942_CR47) 2008; 371 C Sudlow (942_CR23) 2015; 12 DF Quail (942_CR17) 2019; 15 SM Grundy (942_CR18) 2004; 109 P Wu (942_CR25) 2019; 7 M Went (942_CR45) 2020; 4 A Fry (942_CR58) 2017; 186 AJ Cozzo (942_CR6) 2017; 8 J Bowden (942_CR56) 2015; 44 Martin Alicia R (942_CR57) 2019; 51 J Bowden (942_CR30) 2016; 40 A Gkatzionis (942_CR59) 2019; 48 FP Hartwig (942_CR31) 2017; 46 BE Henderson (942_CR22) 2000; 21 S Burgess (942_CR33) 2014; 43 J Park (942_CR4) 2014; 10 M Coelho (942_CR2) 2013; 9 BL Perry (942_CR50) 2013; 43 N Nagata (942_CR53) 2014; 135 T Masuda (942_CR12) 2020; 111 S Burgess (942_CR32) 2020; 11 AG Renehan (942_CR44) 2009; 10 |
| References_xml | – reference: LockeAEKahaliBBerndtSIJusticeAEPersTHDayFRGenetic studies of body mass index yield new insights for obesity biologyNature20155181972061:CAS:528:DC%2BC2MXislehtL8%3D25673413438221110.1038/nature14177 – reference: PlotnikovDGuggenheimJAMendelian randomisation and the goal of inferring causation from observational studies in the vision sciencesOphthalmic Physiol Opt20193911253062874310.1111/opo.12596 – reference: NiGvan der WerfJZhouXHypponenEWrayNRLeeSHGenotype-covariate correlation and interaction disentangled by a whole-genome multivariate reaction norm modelNat Commun20191031110177652761210.1038/s41467-019-10128-w – reference: IttmannMHuangJRadaelliEMartinPSignorettiSSullivanRAnimal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeCancer Res2013732718361:CAS:528:DC%2BC3sXmvVShtLs%3D23610450364402110.1158/0008-5472.CAN-12-4213 – reference: RenehanAGBariatric surgery, weight reduction, and cancer preventionThe Lancet Oncology20091064011955616410.1016/S1470-2045(09)70170-6 – reference: DallalCMBrintonLABauerDCBuistDSCauleyJAHueTFObesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohortEndocr Relat Cancer201320151601:CAS:528:DC%2BC3sXlt1WnsL4%3D23222000403832610.1530/ERC-12-0229 – reference: HendersonBEFeigelsonHSHormonal carcinogenesisCarcinogenesis200021427331:CAS:528:DC%2BD3cXitVeisL4%3D1068886210.1093/carcin/21.3.427 – reference: Amin HA, Kaewsri P, Yiorkas AM, Cooke H, Blakemore AI, Drenos F Increased adiposity is protective for breast and prostate cancer: a Mendelian randomisation study using up to 132,413 breast cancer cases and 85,907 prostate cancer cases. medRxiv. 2020:26. https://doi.org/10.1101/2020.04.02.20049031. – reference: NagataNSakamotoKAraiTNiikuraRShimboTShinozakiMVisceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenomaInt J Cancer20141352273811:CAS:528:DC%2BC2cXlvFWntLs%3D2469206410.1002/ijc.28872 – reference: Perez-CornagoAApplebyPNPischonTTsilidisKKTjonnelandAOlsenATall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort studyBMC Med20171528701188550868710.1186/s12916-017-0876-7 – reference: QuailDFDannenbergAJThe obese adipose tissue microenvironment in cancer development and progressionNat Rev Endocrinol2019151395430459447637417610.1038/s41574-018-0126-x – reference: DaviesNMGauntTRLewisSJHollyJDonovanJLHamdyFCThe effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortiumCancer Causes Control20152616031626387087459689910.1007/s10552-015-0654-9 – reference: PainterJNO’MaraTAMarquartLWebbPMAttiaJMedlandSEGenetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancerCancer Epidemiol Biomarkers Prev20162515031027550749509308210.1158/1055-9965.EPI-16-0147 – reference: WentMCornishAJLawPJKinnersleyBvan DuinMWeinholdNSearch for multiple myeloma risk factors using Mendelian randomizationBlood Adv20204217291:CAS:528:DC%2BB3cXis12ks7vP32433745725254110.1182/bloodadvances.2020001502 – reference: BurgessSFoleyCNAllaraEStaleyJRHowsonJMMA robust and efficient method for Mendelian randomization with hundreds of genetic variantsNat Commun2020111:CAS:528:DC%2BB3cXivFOgsbc%3D31953392696905510.1038/s41467-019-14156-4 – reference: Martinez-UserosJGarcia-FoncillasJObesity and colorectal cancer: molecular features of adipose tissueJ Transl Med20161426801617472267410.1186/s12967-016-0772-5 – reference: BowdenJDavey SmithGBurgessSMendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionInt J Epidemiol2015445122526050253446979910.1093/ije/dyv080 – reference: WuPGiffordAMengXLiXCampbellHVarleyTMapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial EvaluationJMIR Med Inform20197e1432531553307691122710.2196/14325 – reference: TakahashiHCornishAJSudALawPJDisney-HoggLCalvocoressiLMendelian randomization provides support for obesity as a risk factor for meningiomaSci Rep2019930670737634303110.1038/s41598-018-36186-6 – reference: BurgessSSample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcomeInt J Epidemiol201443922924608958405213710.1093/ije/dyu005 – reference: RenehanAGTysonMEggerMHellerRFZwahlenMBody-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet20083715697810.1016/S0140-6736(08)60269-X – reference: DengTLyonCJBerginSCaligiuriMAHsuehWAObesity, inflammation, and cancerAnnu Rev Pathol201611421491:CAS:528:DC%2BC28XotF2qtLk%3D2719345410.1146/annurev-pathol-012615-044359 – reference: NagleCMMarquartLBainCJO’BrienSLahmannPHQuinnMImpact of weight change and weight cycling on risk of different subtypes of endometrial cancerEur J Cancer2013492717261:STN:280:DC%2BC3srkvFWiuw%3D%3D2358343810.1016/j.ejca.2013.03.015 – reference: FryALittlejohnsTJSudlowCDohertyNAdamskaLSprosenTComparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general populationAm J Epidemiol201718610263428641372586037110.1093/aje/kwx246 – reference: KabatGCKimMYLeeJSHoGYGoingSBBeebe-DimmerJMetabolic obesity phenotypes and risk of breast cancer in postmenopausal womenCancer Epidemiol Biomarkers Prev2017261730528939589698633410.1158/1055-9965.EPI-17-0495 – reference: ThriftAPGongJPetersUChang-ClaudeJRudolphASlatteryMLMendelian randomization study of body mass index and colorectal cancer riskCancer Epidemiol Biomarkers Prev20152410243125976416449096010.1158/1055-9965.EPI-14-1309 – reference: DixonSCNagleCMThriftAPPharoahPDPearceCLZhengWAdult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization studyInt J Epidemiol2016458849527401727564457310.1093/ije/dyw158 – reference: WentMSudALawPJJohnsonDCWeinholdNForstiAAssessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approachBlood Cancer J201771:STN:280:DC%2BC1cnptVCmuw%3D%3D28622301552039510.1038/bcj.2017.48 – reference: CozzoAJFullerAMMakowskiLContribution of adipose tissue to development of cancerCompr Physiol201782378229357128580662710.1002/cphy.c170008 – reference: CornishAJLawPJTimofeevaMPalinKFarringtonSMPallesCModifiable pathways for colorectal cancer: a mendelian randomisation analysisThe Lancet Gastroenterol Hepatol2020555623166858410.1016/S2468-1253(19)30294-8 – reference: Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D et al. The MR-base platform supports systematic causal inference across the human phenome. Elife 2018;7:e34408. – reference: GkatzionisABurgessSContextualizing selection bias in Mendelian randomization: how bad is it likely to be?Int J Epidemiol2019486917013032542210.1093/ije/dyy202 – reference: Flanders WD, Augestad LB Methodological issues in observational studies of obesity and mortality. Norsk Epidemiologi. 2011;20(2):143–148. – reference: TaylorRWGrantAMWilliamsSMGouldingASex differences in regional body fat distribution from pre- to postpubertyObesity (Silver Spring)2010181410610.1038/oby.2009.399 – reference: GrundySMBrewerHBJr.CleemanJISmithSCJr.LenfantCAmerican HeartADefinition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionCirculation200410943381474495810.1161/01.CIR.0000111245.75752.C6 – reference: WCRF/AICR. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective A summary of the third Expert Report World Cancer Research Fund/American Institute for Cancer Research 2018. Report no.: Expert Report 2018. – reference: Biobank TU Genotyping and quality control of UK Biobank, a large-scale, extensively phenotyped prospective resource. 2015. – reference: DaviesNMeaThe effects of height and BMI on prostate cancer inidence and mortality: a mendelain randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortiumCancer Causes Control20152616031626387087459689910.1007/s10552-015-0654-9 – reference: Álvarez-CastroPSangiao-AlvarellosSBrandón-SandáICordidoFEndocrine function in obesityEndocrinología y Nutrición (English Edition)2011584223210.1016/j.endoen.2011.05.008 – reference: Biobank U UK Biobank Cancer Numbers Summary Report. In. UK: UK Biobank, 2020. – reference: BowdenJDavey SmithGHaycockPCBurgessSConsistent estimation in mendelian randomization with some invalid instruments using a weighted median estimatorGenet Epidemiol2016403041427061298484973310.1002/gepi.21965 – reference: NMISystemic correlates of white adipose tissue inflammation in early-stage breast cancerClin. Cancer Res2016222283910.1158/1078-0432.CCR-15-2239 – reference: HartwigFPDavey SmithGBowdenJRobust inference in summary data Mendelian randomization via the zero modal pleiotropy assumptionInt J Epidemiol20174619859829040600583771510.1093/ije/dyx102 – reference: ParkJMorleyTSKimMCleggDJSchererPEObesity and cancer-mechanisms underlying tumour progression and recurrenceNat Rev Endocrinol201410455651:CAS:528:DC%2BC2cXpvFWgsb8%3D24935119437443110.1038/nrendo.2014.94 – reference: WinklerTWGuntherFHollererSZimmermannMLoosRJKutalikZA joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implicationsNat Commun2018929769528595607910.1038/s41467-018-04124-9 – reference: PerryBLPescosolidoBABucholzKEdenbergHKramerJKupermanSGender-specific gene-environment interaction in alcohol dependence: the impact of daily life events and GABRA2Behav Genet2013434021423974430444104410.1007/s10519-013-9607-9 – reference: MasudaTOgawaKKamataniYMurakamiYKimuraTOkadaYA Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in JapaneseCancer Sci20201114646511:CAS:528:DC%2BB3cXitFGlsLbO32981178773416210.1111/cas.14667 – reference: CoelhoMOliveiraTFernandesRBiochemistry of adipose tissue: an endocrine organArch Med Sci201391912001:CAS:528:DC%2BC3sXht1Kgsr3P23671428364882210.5114/aoms.2013.33181 – reference: Alicia RMartinMKYoichiroKamataniYukinoriOkadaBenjamin M.NealeMark JDalyClinical use of current polygenic risk scores may exacerbate health disparitiesNature Genetics2019515849110.1038/s41588-019-0379-x – reference: RosatoVZucchettoABosettiCDal MasoLMontellaMPelucchiCMetabolic syndrome and endometrial cancer riskAnn Oncol20112288491:STN:280:DC%2BC3MzkvVWhtA%3D%3D2093764510.1093/annonc/mdq464 – reference: BMJ. Reading Mendelian Randomization studies: a guide, glossary, and cheklist for clinicians. BMJ Open 2018;362:k601. – reference: HyppönenEMulugetaAZhouASanthanakrishnanVKA data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK BiobankThe Lancet Digital Health20191e116e1263332326210.1016/S2589-7500(19)30028-7 – reference: GIANT. GIANT consortium data files. In. March 2019 ed, 2019. – reference: GuoYWarren AndersenSShuXOMichailidouKBollaMKWangQGenetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of european descentPLoS Med201613e100210527551723499502510.1371/journal.pmed.1002105 – reference: SudlowCGallacherJAllenNBeralVBurtonPDaneshJUK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old agePLoS Med201512e100177925826379438046510.1371/journal.pmed.1001779 – reference: Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014;106(11):1–8. – reference: PhillipsCMMetabolically healthy obesity across the life course: epidemiology, determinants, and implicationsAnn NY Acad Sci20171391851002772394010.1111/nyas.13230 – reference: Lauby-SecretanBScocciantiCLoomisDGrosseYBianchiniFStraifKBody fatness and cancer-viewpoint of the IARC Working GroupN Engl J Med2016375794827557308675486110.1056/NEJMsr1606602 – reference: WacholderSRothmanNCaporasoNPopulation stratification in epidemiologic studies of common genetic variants and cancer: quantification of biasJ Natl Cancer Inst200092115181:STN:280:DC%2BD3cvlvFeguw%3D%3D1090408810.1093/jnci/92.14.1151 – volume: 51 start-page: 584 year: 2019 ident: 942_CR57 publication-title: Nature Genetics doi: 10.1038/s41588-019-0379-x – volume: 18 start-page: 1410 year: 2010 ident: 942_CR49 publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2009.399 – volume: 111 start-page: 4646 year: 2020 ident: 942_CR12 publication-title: Cancer Sci doi: 10.1111/cas.14667 – volume: 1391 start-page: 85 year: 2017 ident: 942_CR39 publication-title: Ann NY Acad Sci doi: 10.1111/nyas.13230 – volume: 26 start-page: 1730 year: 2017 ident: 942_CR38 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-17-0495 – volume: 7 start-page: e14325 year: 2019 ident: 942_CR25 publication-title: JMIR Med Inform doi: 10.2196/14325 – ident: 942_CR7 doi: 10.5324/nje.v20i2.1334 – volume: 15 start-page: 139 year: 2019 ident: 942_CR17 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-018-0126-x – volume: 7 year: 2017 ident: 942_CR46 publication-title: Blood Cancer J doi: 10.1038/bcj.2017.48 – volume: 14 year: 2016 ident: 942_CR52 publication-title: J Transl Med doi: 10.1186/s12967-016-0772-5 – volume: 5 start-page: 55 year: 2020 ident: 942_CR15 publication-title: The Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30294-8 – volume: 135 start-page: 2273 year: 2014 ident: 942_CR53 publication-title: Int J Cancer doi: 10.1002/ijc.28872 – ident: 942_CR54 doi: 10.1136/bmj.k601 – volume: 40 start-page: 304 year: 2016 ident: 942_CR30 publication-title: Genet Epidemiol doi: 10.1002/gepi.21965 – volume: 11 year: 2020 ident: 942_CR32 publication-title: Nat Commun doi: 10.1038/s41467-019-14156-4 – volume: 375 start-page: 794 year: 2016 ident: 942_CR48 publication-title: N Engl J Med doi: 10.1056/NEJMsr1606602 – volume: 24 start-page: 1024 year: 2015 ident: 942_CR10 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-14-1309 – volume: 8 start-page: 237 year: 2017 ident: 942_CR6 publication-title: Compr Physiol doi: 10.1002/cphy.c170008 – volume: 45 start-page: 884 year: 2016 ident: 942_CR14 publication-title: Int J Epidemiol doi: 10.1093/ije/dyw158 – volume: 58 start-page: 422 year: 2011 ident: 942_CR21 publication-title: Endocrinología y Nutrición (English Edition) doi: 10.1016/j.endoen.2011.05.008 – volume: 21 start-page: 427 year: 2000 ident: 942_CR22 publication-title: Carcinogenesis doi: 10.1093/carcin/21.3.427 – ident: 942_CR11 doi: 10.1093/jnci/dju252 – volume: 26 start-page: 1603 year: 2015 ident: 942_CR13 publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0654-9 – volume: 25 start-page: 1503 year: 2016 ident: 942_CR40 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-16-0147 – volume: 92 start-page: 1151 year: 2000 ident: 942_CR55 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.14.1151 – volume: 9 start-page: 191 year: 2013 ident: 942_CR2 publication-title: Arch Med Sci doi: 10.5114/aoms.2013.33181 – volume: 11 start-page: 421 year: 2016 ident: 942_CR3 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-012615-044359 – volume: 371 start-page: 569 year: 2008 ident: 942_CR47 publication-title: The Lancet doi: 10.1016/S0140-6736(08)60269-X – ident: 942_CR35 doi: 10.1101/2020.04.02.20049031 – ident: 942_CR24 – volume: 4 start-page: 2172 year: 2020 ident: 942_CR45 publication-title: Blood Adv doi: 10.1182/bloodadvances.2020001502 – volume: 73 start-page: 2718 year: 2013 ident: 942_CR5 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-4213 – volume: 44 start-page: 512 year: 2015 ident: 942_CR56 publication-title: Int J Epidemiol doi: 10.1093/ije/dyv080 – ident: 942_CR28 – volume: 13 start-page: e1002105 year: 2016 ident: 942_CR9 publication-title: PLoS Med doi: 10.1371/journal.pmed.1002105 – volume: 49 start-page: 2717 year: 2013 ident: 942_CR43 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2013.03.015 – volume: 43 start-page: 402 year: 2013 ident: 942_CR50 publication-title: Behav Genet doi: 10.1007/s10519-013-9607-9 – volume: 46 start-page: 1985 year: 2017 ident: 942_CR31 publication-title: Int J Epidemiol doi: 10.1093/ije/dyx102 – volume: 109 start-page: 433 year: 2004 ident: 942_CR18 publication-title: Circulation doi: 10.1161/01.CIR.0000111245.75752.C6 – volume: 22 start-page: 884 year: 2011 ident: 942_CR41 publication-title: Ann Oncol doi: 10.1093/annonc/mdq464 – volume: 10 year: 2019 ident: 942_CR51 publication-title: Nat Commun doi: 10.1038/s41467-019-10128-w – volume: 186 start-page: 1026 year: 2017 ident: 942_CR58 publication-title: Am J Epidemiol doi: 10.1093/aje/kwx246 – volume: 10 start-page: 455 year: 2014 ident: 942_CR4 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2014.94 – volume: 43 start-page: 922 year: 2014 ident: 942_CR33 publication-title: Int J Epidemiol doi: 10.1093/ije/dyu005 – ident: 942_CR1 – volume: 9 year: 2019 ident: 942_CR16 publication-title: Sci Rep doi: 10.1038/s41598-018-36186-6 – volume: 518 start-page: 197 year: 2015 ident: 942_CR26 publication-title: Nature doi: 10.1038/nature14177 – volume: 1 start-page: e116 year: 2019 ident: 942_CR29 publication-title: The Lancet Digital Health doi: 10.1016/S2589-7500(19)30028-7 – ident: 942_CR27 – ident: 942_CR34 doi: 10.7554/eLife.34408 – volume: 39 start-page: 11 year: 2019 ident: 942_CR8 publication-title: Ophthalmic Physiol Opt doi: 10.1111/opo.12596 – volume: 48 start-page: 691 year: 2019 ident: 942_CR59 publication-title: Int J Epidemiol doi: 10.1093/ije/dyy202 – volume: 9 year: 2018 ident: 942_CR20 publication-title: Nat Commun doi: 10.1038/s41467-018-04124-9 – volume: 10 start-page: 640 year: 2009 ident: 942_CR44 publication-title: The Lancet Oncology doi: 10.1016/S1470-2045(09)70170-6 – volume: 26 start-page: 1603 year: 2015 ident: 942_CR36 publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0654-9 – volume: 15 year: 2017 ident: 942_CR37 publication-title: BMC Med doi: 10.1186/s12916-017-0876-7 – volume: 12 start-page: e1001779 year: 2015 ident: 942_CR23 publication-title: PLoS Med doi: 10.1371/journal.pmed.1001779 – volume: 22 start-page: 2283 year: 2016 ident: 942_CR19 publication-title: Clin. Cancer Res doi: 10.1158/1078-0432.CCR-15-2239 – volume: 20 start-page: 151 year: 2013 ident: 942_CR42 publication-title: Endocr Relat Cancer doi: 10.1530/ERC-12-0229 |
| SSID | ssj0005502 ssj0033214 |
| Score | 2.4957368 |
| Snippet | Background
Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic... Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic... Background Observational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic... BackgroundObservational and Mendelian randomization (MR) studies link obesity and cancer, but it remains unclear whether these depend upon related metabolic... |
| SourceID | proquest gale pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2657 |
| SubjectTerms | 631/208 631/67 692/308/174 692/499 692/699/67 Abnormalities Adipose tissue Adolescent Adult Biobanks Breast cancer Cancer Cohort Studies Complications and side effects Confidence intervals Endometrial cancer Endometrium Epidemiology Female Genetic aspects Health Promotion and Disease Prevention Health risks Humans Internal Medicine Lipids Male Medicine Medicine & Public Health Mendelian Randomization Analysis - methods Metabolic Diseases Metabolism Middle Aged Multiple myeloma Neoplasms - diagnosis Neoplasms - epidemiology Obesity Overweight - diagnosis Overweight - epidemiology Prostate cancer Public Health Randomization Retrospective Studies Risk Risk factors Single-nucleotide polymorphism United Kingdom - epidemiology Variance analysis |
| Title | Adiposity and cancer: a Mendelian randomization analysis in the UK biobank |
| URI | https://link.springer.com/article/10.1038/s41366-021-00942-y https://www.ncbi.nlm.nih.gov/pubmed/34453097 https://www.proquest.com/docview/2600110267 https://www.proquest.com/docview/2566040781 |
| Volume | 45 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1476-5497 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005502 issn: 0307-0565 databaseCode: KQ8 dateStart: 19970101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1476-5497 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005502 issn: 0307-0565 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9trYR4QVC-MkYxEoIHiObGzhcSQu1YNQ01QohKfYsc25EqRrqt3UP_e-4SJ6WT2Eteck7i-D59598BvOORKk1aFL4WsfSltYWfBrzEBVEYjFHMUdB-xyyLzufyYhEuDiBrz8JQWWWrE2tFbVaa9shPCEgdTVUQxV-vrn3qGkXZ1baFhnKtFcyXGmLsEPoBIWP1oD85y3783BV9hLxDlxLUo6fFSUQ_IHRnarhITtao2yOqzsVYGwOgwN_u2a272vsf83Unn1qbqeljeOT8SzZuGOIJHNhqAN63pd2w98yBgF6yrMXgH8CDmcuuD2Cw8yGRuO5_vn4KF2OzrEu7tkxVhmlik5vPTLEZ7Z7TLglDe2dWf9yJTqRqcE7YsmLoXrL5d1YsUW1Uv5_BfHr26_Tcdx0YfC1jsfGt0NoYk9gI41XN0yBRURroRCZKxyooAm5CdFgsCnaq8GcpNHVxQBhhIrVaSvEcetWqsi-BoaCb2OJjShFJbUYJj3WkQlkUpYk1Lz0Ytf831w6enLpkXOZ1mlwkebMmOb4mr9ck33rwsRtz1YBz3Ev9hpYtbw6YdpKdj6NEiDTCuNODDzUFyTa-Wyt3RAFnQChZe5THe5Qok3r_dssaudMJ63zHwR687W7TSKpzq-zqFmnQu-aUWh158KJhqW5mQspQ8BRHf2p5bPfw_0_76P5veQUPA2LzukLnGHqbm1v7Gv2sTTGEw3gR4zU5HQ2hP55OJtnQCdRfqxEgXQ |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIgEXBOG1UKiReBxgVcf2vpAQilqqtGlyaqTejNf2ShHtpm1SofwpfiMz-0iaSvTW8469653xPDzjbwA-8NgULsvz0MpEhcr7PMwEL5AhBoMxijlyOu8YjuL-WB2eRCcb8Le9C0Nlla1OrBS1m1o6I98hIHU0VSJOfpxfhNQ1irKrbQuNWiwGfvEHQ7bZ94M95O9HIfZ_Hu_2w6arQGhVIuehl9Y651IfYwxmeSZSE2fCpio1NjEiF9xFaIQ9Cmtm0AIaVN-JINwrmXmrlMR578F9JUVCiiDdvVZSEvEldpWkDkAtCiN6GVFzY4fLdGeGliOm2l-M5DG8EuFizSretA3XjOONbG1lBPefwOPGe2W9WtyewoYvOxDsTfycfWINxOgpG7UI_x14MGxy9x3orDxUJK66q8-ewWHPTarCsQUzpWOWhPDyGzNsSGfzdAbD0Jq66VlzXxSpahQVNikZOq9sPGD5BJVS-fs5jO-EEy9gs5yW_hUwVCMu8ThNIWNlXTfliY1NpPK8cInlRQDd9v9q24CfUw-OU10l4WWqa55ofI2ueKIXAXxZjjmvoT9upd4mtun6-upSb-henEqZxRjVBvC5oiDNge-2prkAgSsgDK41yq01Stzxdv1xKxq60TgzvdofAbxfPqaRVEVX-ukV0qDvzilx2w3gZS1Sy5VJpSLJMxz9tZWx1eT_X_br279lGx72j4dH-uhgNHgDjwSJfFULtAWb88sr_xY9unn-rtpGDH7d9b79B4noUYg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw9GgMaeIFQbkFBjMSlweImtpOnCAhVFGqbaUVD1Tam-fYjlQx0rF2Qv01vo5zcmnpJPa25xw7cc7d5wbwKkpM4bI8D61QMpTe52HGowIRYtAZI58jp_uO8SQ5nMrjk_hkB_60tTCUVtnKxEpQu7mlO_IuNVJHVcUT1S2atIhvg-Gn818hTZCiSGs7TqMmkZFf_Ub3bfHxaIC4fs358Mv3z4dhM2EgtFKJZeiFtc651Cfoj9ko46lJMm5TmRqrDM955GJUyB4JNzOoDQ2KcsWpB5bIvJVS4L634LYSIqN0QnWiNuklcbTuYyVoGlDbkREtjrip3olE2l2gFkkoDxi9enS1eLja0pBX9cQ_ivJK5LZSiMN7cLexZFm_Jr37sOPLDgSDmV-yN6xpN3rGJm23_w7sjZs4fgc6G2sVgatJ64sHcNx3syqJbMVM6Zglgrz4wAwb0z093ccw1Kxu_rOpHUWouqMKm5UMDVk2HbF8hgKq_PEQpjeCiUewW85L_wQYihSnPG5TiERa10sjZRMTyzwvnLJREUCv_b_aNo3QaR7Hma4C8iLVNU40vkZXONGrAN6t15zXbUCuhT4gtOm6lHUtQ3Q_SZFSEvRwA3hbQZAUwXdb0xRD4AmoH9cW5P4WJHK_3X7ckoZupM9Cb3glgJfrx7SSMupKP79EGLTjIwri9gJ4XJPU-mRCylhEGa5-39LYZvP_H_vp9d9yAHvIsfrr0WT0DO5wovgqLWgfdpcXl_45GnfL_EXFRQxOb5pt_wJgsVX3 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adiposity+and+cancer%3A+a+Mendelian+randomization+analysis+in+the+UK+biobank&rft.jtitle=International+Journal+of+Obesity&rft.au=Ahmed%2C+Muktar&rft.au=Mulugeta%2C+Anwar&rft.au=Lee%2C+S.+Hong&rft.au=M%C3%A4kinen%2C+Ville-Petteri&rft.date=2021-12-01&rft.pub=Nature+Publishing+Group&rft.issn=0307-0565&rft.volume=45&rft.issue=12&rft.spage=2657&rft_id=info:doi/10.1038%2Fs41366-021-00942-y&rft.externalDocID=A683396998 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon |